Minute Insight: NeuroOne Amends Deal With Zimmer Biomet To Shore Up Balance Sheet

03 Aug 2022

Zimmer Biomet agreed to amend its exclusive development and distribution agreement with NeuroOne to pay $3.5m for 350,000 of stock. The deal will help NeuroOne continue to develop its Evo stereoelectroencephalography brain-mapping electrodes without further diluting the company’s stock.

Minute Insight — • Source: Informa/Alamy

Zimmer Biomet has agreed to provide NeuroOne, a Minnesota developer of ultrathin electrode technology, with much-needed cash as the companies develop technologies for minimally invasive placement of a stereoelectroencephalography (sEEG) electrode on the brain.

Under a 2020 Exclusive Development and Distribution Agreement, Zimmer Biomet obtained exclusive global distribution rights to distribute NeuroOne’s Evo...